Improving Health, Health Care and Quality of Life
MINNEAPOLIS, May 20, 2015 /PRNewswire-USNewswire/ -- DaVita Clinical Research (DCR), a specialty contract research organization with services spanning a broad spectrum of drug and device development, today recognizes the principal investigators who help enhance the future of medicine through clinical trials.
For 30 years, DCR has worked with physicians and other health care professionals – referred to as principal investigators (PI) – to successfully enroll and manage clinical trials. PIs are responsible for overseeing research protocols for the duration of a clinical trial. DCR works with a large network of more than150 PI in many therapeutic areas across the U.S. and is also expanding internationally. DCR's Investigator Appreciation Day will coincide with International Clinical Trials Day, also celebrated on May 20.
The public has a chance to share why they are grateful for those who conduct research on Instagram and other social media channels using the hashtag #ISupportResearch. Individuals who want to participate can download the thank you sign at DaVitaClinicalResearch.com/ResearchMatters.
"We're incredibly appreciative for our principal investigators," said Amy Young, general manager for DCR. "We want to honor them for their work and the contributions they make to advance the practice of medicine."
DCR continues to expand its capabilities across the spectrum of drug and device development, early- and late-phase clinical trials, health economics and outcome research, real-world health care data and medical communications. In addition to its clinical pharmacology unit (CPU) in Minneapolis, Minnesota, DCR has a second CPU in Lakewood, Colorado, as well as a network of affiliated PIs in four states through its HealthCare Partners clinical research arm. To learn more, visit davitaclinicalresearch.com.
To learn about current DCR clinical trials and how to enroll in a clinical trial, visit iSupportResearch.com.
DaVita Clinical Research and DCR are registered trademarks of DaVita Healthcare Partners Inc.
About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2015, DaVita Kidney Care operated or provided administrative services at 2,197 outpatient dialysis centers located in the United States serving approximately 174,000 patients. The company also operated 93 outpatient dialysis centers located in 10 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, Florida and Colorado in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of March 31, 2015 HealthCare Partners provided integrated care management for approximately 830,000 patients. For more information, please visit DaVitaHealthCarePartners.com.
About DaVita Clinical Research (DCR)
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita HealthCare Partners, Inc.,uses its extensive, applied database and real-world healthcare experience to assist pharmaceutical and medical device companies in the design, recruitment and completion of retrospective, prospective pragmatic and clinical trials. DCR's scientific and clinical expertise spans the lifecycle of product development with more than 175 client companies. DCR's Early Clinical Research unit (Phase I-IIa) and Clinical Development (Phase IIb through post-marketing) network of physicians and investigative sites, Real-World Healthcare Data, Health Economics & Outcomes Research,and Medical Communications are focused on providing world-class research in both complex/specialty populations and therapeutic areas, and especially in CKD and ESRD populations. To learn more about DCR, visit www.davitaclinicalresearch.com.
SOURCE DaVita Clinical Research